Map, join and drive European activities for advanced therapy medicinal product development and implementation for the benefit of patients and society
Advanced Therapy Medicinal Products (ATMPs) are medicines based on genes, cells and tissues for human use that can sustainably improve or even cure diseases that currently have no or inadequate standard-of-care options. However, several hurdles remain unsolved and prevent the implementation of these innovative therapy options into effective clinical application. The research project JOIN4ATMP aims to accelerate European ATMP development and ensure widespread ATMP access while fostering the expansion of strong Good Manufacturing Practices (GMP) on a European level. To achieve this ambitious goal, the project will focus on three processes: categorising obstacles to ATMP progress, mapping potential solutions based on real-world use cases and designing actionable recommendations.
- Professor Dr med Annette KünkeleCharité – University Hospital BerlinEmail